Key Therapeutics is a leading specialty pharmaceutical provider with a focus on acquiring, developing, and commercializing diagnostic platforms and prescription drugs for the U.S. market. The company, founded in 2015, prides itself on being the "key" innovator of first-line therapies in Mental Health, Women's Health, Urology, and Pediatrics. Key Therapeutics' goal is to provide quality and affordable products that are accessible to patients seeking relief. The company has been committed to this mission for over 10 years, continually evolving into an innovative pharmaceutical manufacturer, providing brands that are key to their patients' quality of life. Key Therapeutics operates in the Pharmaceutical and Retail industries, aiming to make a meaningful impact on patient care. While no specific information is available about the company's headquarters or last investment, it is clear that Key Therapeutics is dedicated to advancing healthcare through their specialized focus on various therapeutic areas.
There is no investment information
No recent news or press coverage available for Key Therapeutics.